Life Sciences

Contraceptive Drugs Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

The global contraceptive drugs market size was evaluated at $14,324.12 million in 2019, and is estimated to garner $24,412.22 million by 2027, registering a CAGR of 6.9% during ...

Report Code : A09485 | Pages : 168 | Category : Life Sciences

Vitiligo Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Vitiligo is a hypopigmentation skin disorder characterized by the white patches on the skin that causes the loss of skin color due to low concentration of melanin in ...

Report Code : A10445 | Category : Life Sciences

Genitourinary Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Genitourinary tract agents are medicines used to treat conditions of reproductive organs and excretory system or urinary tract.

Report Code : A10496 | Category : Life Sciences

Dyslipidemia Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Dyslipidemia is the unhealthy or abnormal levels of one or more kinds of lipids (fats) in patients’ blood stream. Blood contains three main types of lipid namely high-density ...

Report Code : A11423 | Category : Life Sciences

Anthelmintic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global anthelmintic drugs market size was valued at $1.0 billion in 2022, and is projected to reach $1.5 billion by 2032, growing at a CAGR of 3.8% from 2023 to 2032.

Report Code : A11501 | Pages : 250 | Category : Life Sciences

Sarcoidosis Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Sarcoidosis is an inflammatory disease in which clumps of inflammatory cells form in various organs called granulomas. These granulomas may cause organ inflammation. This disease is triggered by ...

Report Code : A11561 | Category : Life Sciences

Dementia Drugs Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global dementia drugs market was valued at $8.7 billion in 2021, and is projected to reach $19.7 billion by 2031, growing at a CAGR of 8.5% from 2022 to 2031.

Report Code : A12014 | Pages : 265 | Category : Life Sciences

Psychedelic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global psychedelic drugs market was valued at $0.7 billion in 2022, and is projected to reach $2.6 billion by 2032, growing at a CAGR of 13.4% from 2023 to 2032.

Report Code : A12068 | Pages : 230 | Category : Life Sciences

Atherosclerosis Drugs Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global atherosclerosis drugs market was valued at $20.6 billion in 2022, and is projected to reach $27.7 billion by 2032, growing at a CAGR of 3% from 2023 to 2032.

Report Code : A13185 | Pages : 250 | Category : Life Sciences

Neurodegenerative Drugs Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global neurodegenerative drugs market was valued at $36,277.20 million in 2021 and is estimated to reach $74,809.38 million by 2031, growing at a CAGR of 7.5% from 2022 to 2031.

Report Code : A13213 | Pages : 300 | Category : Life Sciences

Albinism Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Albinism generally preferred to oculocuntaneous albinism which is group of disorders having no production of pigment melanin. People who suffer from albinism have vision, skin, and hair problems. ...

Report Code : A13333 | Category : Life Sciences

Antiglaucoma Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Antiglaucoma drugs are used in the treatment of glaucoma, in which the optic nerve may get damaged resulting in irreversible loss of vision. In glaucoma, excessive amount of ...

Report Code : A13336 | Category : Life Sciences

Antithrombotic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Antithrombotic drugs help to prevent thrombus or blood clots from forming. These medicines used to reduce the formation of blood clots by reducing the body's ability to form ...

Report Code : A13337 | Category : Life Sciences

Dysentery Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Dysentery is a type disease related to gastroenteritis that results in bloody diarrhea. Fever, abdominal pain, and feeling of incomplete defections are different types of symptoms occur during ...

Report Code : A13351 | Category : Life Sciences

Lifestyle Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Lifestyle drugs are the type of medications used in the treatment of non-threatening and non-painful condition such as baldness, erectile dysfunction, acne, and others. Non-medical problems and minor ...

Report Code : A13368 | Category : Life Sciences

Synthetic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Synthetic drug is pharmaceutical medication created through man made engineering in contrast to natural ingredients. They are also known as new psychoactive substances (NSPs) and aim at mimicking ...

Report Code : A13383 | Category : Life Sciences

Nephrology Drugs Market: Global Opportunity Analysis and Industry Forecast, 2021–2030

The global nephrology drugs market was valued at $14,501.75 million in 2020, and is projected to reach $23,405.42 million by 2030, registering a CAGR of 5.0% from 2021 ...

Report Code : A13396 | Pages : 267 | Category : Life Sciences

Endocarditis Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Endocarditis is an infection that transpires at the inner lining of the heart valves and heart chambers. If not treated at an early stage, it could damage the ...

Report Code : A13397 | Category : Life Sciences

Dystonia Drugs Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global dystonia drugs market was valued at $806.7 million in 2021, and is projected to reach $1,378.67 million by 2031, growing at a CAGR of 5.5% from 2022 to 2031.

Report Code : A13938 | Pages : 210 | Category : Life Sciences

Endocrinology Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Endocrinology is the branch of medicine that deals with endocrine and metabolic disorders. Three different classes of hormones based on their chemical composition include amines, steroids, and peptides & proteins.

Report Code : A13939 | Category : Life Sciences

Dihydralazine Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Dihydralazine is a drug belonging to the class of potassium channel openers, and is used in the treatment of hypertension or high blood pressure.

Report Code : A14375 | Category : Life Sciences

Otic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Otitis is an inflammation in the middle ear which resulting in dysfunction of the eustachian tube that occurs during viral upper respiratory tract infection. The eustachian tube links ...

Report Code : A14457 | Category : Life Sciences

Anticoccidial Drugs Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global anticoccidial drugs market was valued at $171.3 million in 2021, and is projected to reach $257.8 million by 2031, growing at a CAGR of 4.2% from 2022 to 2031.

Report Code : A14844 | Pages : 220 | Category : Life Sciences

Drugs for Vulvovaginal Candidiasis Market  by Drug Class : Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global drugs for vulvovaginal candidiasis market  was valued at $1.0 billion in 2023, and is projected to reach $1.6 billion by 2033, growing at a CAGR of 4.4% from 2024 to 2033.

Report Code : A324411 | Pages : 240 | Category : Life Sciences

Drugs For Cytomegalovirus by Drug Type : Global Opportunity Analysis and Industry Forecast, 2022-2032

Report Code : A50524 | Category : Life Sciences